Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.12.2023 | Case report

Fluconazole/Tretinoin

Hypercalcaemia secondary to pharmacokinetic drug-drug interaction: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is: Drug interaction
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Akman BT, et al. Hypercalcemia associated with interaction between all trans retinoic acid and fluconazole in an acute promyelocytic leukemia and acquired hypoparathyroidism case. Journal of Oncology Pharmacy Practice : Jan 2023. Available from: URL: https://dx.doi.org/10.1177/10781552231216050 [summarized from abstract] Akman BT, et al. Hypercalcemia associated with interaction between all trans retinoic acid and fluconazole in an acute promyelocytic leukemia and acquired hypoparathyroidism case. Journal of Oncology Pharmacy Practice : Jan 2023. Available from: URL: https://​dx.​doi.​org/​10.​1177/​1078155223121605​0 [summarized from abstract]
Metadaten
Titel
Fluconazole/Tretinoin
Hypercalcaemia secondary to pharmacokinetic drug-drug interaction: case report
Publikationsdatum
01.12.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-52056-7

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Secukinumab

Case report

Rivaroxaban

Case report

Tranexamic-acid